Effect of Different Anti-Asthmatic Treatments on Lung Function and on Exercise-Induced Bronchoconstriction in Children With Asthma
NCT00490243 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2007-06-28
Summary
The present study was conducted to determine the effects of four week treatment with budesonide, montelukast, budesonide with montelukast and budesonide with formoterol in children with atopic asthma on lung function: forced expiratory volume in one second, mid-expiratory flow, peak expiratory flow rate, resistance by the interrupter technique, plethysmographic specific airway resistance, exercise-induced bronchial hyperreactivity and clinical symptoms.
Conditions
Interventions
- DRUG
-
budesonide and montelukast
- DRUG
-
budesonide and formoterol
- DRUG
-
montelukast
- DRUG
-
budesonide
- DRUG
Sponsors & Collaborators
-
Medical University of Lodz
lead OTHER
Principal Investigators
-
Tomasz Grzelewski, MD, PhD · Department of Pediatrics and Allergy, Medical University of Lodz, Poland
-
Iwona Stelmach, MD, PhD, Prof · Department of Pediatrics and Allergy, Medical University of Lodz, Poland
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-07-31
- Completion
- 2006-10-31
Countries
- Poland
Study Locations
More Related Trials
-
A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)
NCT01258803 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Combination Therapy: Montelukast and Inhaled Steroid on Exercise Induced Bronchoconstriction
NCT00462592 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)
NCT00489346 ·Status: COMPLETED ·Phase: PHASE3
-
Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)
NCT00127166 ·Status: COMPLETED ·Phase: PHASE3
-
Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)
NCT00289874 ·Status: COMPLETED ·Phase: PHASE3
-
Montelukast and Loratadine in Children With Asthma
NCT03372473 ·Status: COMPLETED ·Phase: PHASE3
-
Montelukast With Status Asthmaticus, Ages 6-18
NCT00494572 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)
NCT00092131 ·Status: COMPLETED ·Phase: PHASE3
-
Management of Asthma in School-age Children on Therapy
NCT01526161 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Montelukast in Children With Asthma
NCT00675285 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics
NCT02574975 ·Status: UNKNOWN ·Phase: PHASE4
-
Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)
NCT00090142 ·Status: COMPLETED ·Phase: PHASE3
-
Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.
NCT01581710 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Treatment Regimens in Asthmatic Patients
NCT01488773 ·Status: COMPLETED
-
A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
NCT00540839 ·Status: WITHDRAWN ·Phase: PHASE3
-
Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population
NCT01328964 ·Status: COMPLETED
-
Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
NCT00112411 ·Status: COMPLETED ·Phase: PHASE2
-
Leukotriene Receptor Antagonists or Steroids in Pre-School Asthma
NCT00543686 ·Status: COMPLETED ·Phase: PHASE2
-
A Mechanistic Study to Evaluate the Efficacy of Montelukast on Airway Function in Asthma
NCT01841164 ·Status: UNKNOWN ·Phase: NA
-
Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)
NCT00245570 ·Status: COMPLETED ·Phase: PHASE3
-
Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )
NCT00968201 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)
NCT00140881 ·Status: COMPLETED ·Phase: PHASE4
-
Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)
NCT00092144 ·Status: COMPLETED ·Phase: PHASE3
-
Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)
NCT00943683 ·Status: COMPLETED ·Phase: NA
-
Usefulness of Exhaled Breath Condensate for Evaluation of Markers of Airway Inflammation in Children With Asthma
NCT00961155 ·Status: UNKNOWN ·Phase: PHASE2